News

Atopic dermatitis (AD), also referred to as eczema, is a chronic inflammatory skin disorder affecting more than 102.8 million children and 101.3 million adults worldwide. 2 AD is characterized by ...
The Phase 1b trial is designed to evaluate the safety, tolerability, pharmacokinetics, target engagement, and early signs of efficacy of ENV-294 in patients with moderate to severe atopic dermatitis.
Photo: TBS The Akhaura-bound Titas Commuter train travelled approximately eight kilometres in darkness last night (21 June) after its engine's headlight failed, relying on mobile phone torchlights to ...
Barring a major turn of events, it certainly seems like Mitch Marner's time with the Maple Leafs has come to an end. Michael Amato weighs the possibility of a sign-and-trade for Marner and more in ...
The FDA has extended its review of Incyte’s supplemental New Drug Application (sNDA) for ruxolitinib cream 0.75% (Opzelura) for the treatment of mild to moderate atopic dermatitis (AD) in children ...
Industrial Fire Precaution levels (IFPL) range from Level 1 to Level 4 with accompanying restrictions on operations to protect forest resources. Restrictions have not changed, with a 1-hour fire watch ...
However, some of Castleford’s rumoured targets had already agreed to sign before Chester joined the club. Following yet more links to players in the last week, here’s how Castleford’s strongest 17 ...
TOPLINE: Treating atopic dermatitis (AD) with dupilumab vs other systemic agents increased the risk of developing psoriasis over 3 years, a cohort study found. METHODOLOGY: Addressing ...
Key Takeaways Nemolizumab provides significant relief from itch and skin lesions in prurigo nodularis and atopic dermatitis, with sustained efficacy over two years. The biologic targets the ...
Video: What to Know About Treatment of Atopic Dermatitis Based on the 2024 AAD Guidelines —Megan Rogge, MD, associate professor of dermatology at UT Health in Houston, shares her opinion on the ...
Published: June 18, 2025 What to Know About Treatment of Atopic Dermatitis Based on the 2024 AAD Guidelines Adult-onset Atopic Dermatitis: Phenotypically Diverse, So Don’t Miss the Diagnosis ...